UniPharma

therapeutic areas

Cardiology

Cardiology is monitored by UniPharma because shifts in demand, reimbursement, regulation, competition, or supply priorities can reshape procurement and launch planning.

Related insights

Latest articles on Cardiology

April 29, 2026

New PRS Tool Identifies Inherited Risk for Eight Cardiovascular Conditions

A new integrated polygenic risk score tool for eight cardiovascular conditions enables early risk identification and may shift preventive cardiology workflows.

Read insight
April 28, 2026

New Cholesterol Guidelines Expand Pediatric Screening to Age 9

Updated US guidelines now recommend cholesterol screening from age 9. The shift toward earlier prevention will drive demand for lipid-lowering therapies and diagnostic tests.

Read insight
April 28, 2026

Cardiology News Roundup: Braunwald Tribute, Camzyos Afib Risk, New Device Approvals

Key cardiology updates: mavacamten Afib risk, DOAC safety comparisons, new device approvals and FDA clearances.

Read insight
April 28, 2026

Abbott Receives FDA Clearance, CE Mark for Next-Gen AI-powered Coronary Imaging Platform

Abbott's Ultreon 3.0 software integrates OCT and AI to guide stent placement, receiving FDA and CE clearance for PCI workflow improvements.

Read insight